Duplicate Therapy Database™
Improves Clinical Outcomes by Avoiding Unnecessary Therapeutic Duplication
PREVENTS DRUG DUPLICATION
Duplicate Therapy Database™ equips health care providers with accurate, timely alerts to potential duplications in drug therapy. Information in the database is drug-specific, comprehensive and Screens for drugs with similar primary indications or active ingredients.
FEATURES
- Therapeutic duplications for products used for single and multiple therapeutic purposes
- Ingredient duplications for single and multiple ingredient products
- OTC medication duplications
- Codes identifying duplication class, be it an ingredient, mechanism of action or therapeutic indication
- Significance codes to indicate presence of abuse potential
- Duplication Allowance indicator to specify the number of acceptable duplications before providing an alert
BENEFITS
FOR HEALTH CARE FACILITIES
- Supports Drug Utilization Review (DUR)
- Identifies duplications related to ingredients, actions or indications
- Screens for drug duplications with abuse potential
- Improves both clinical and financial outcomes by avoiding toxic or unnecessary therapies
- Reduces risks by protecting against unintentional drug duplication associated with the combined use of prescription and OTC medications
- Enhances the safety of patients being treated by multiple physicians
- Click here to download the PDF
FOR HEALTH CARE PROVIDERS
- Supports Drug Utilization Review (DUR)
- Identifies duplications related to ingredients, actions or indications
- Screens for drug duplications with abuse potential
- Improves both clinical and financial outcomes by avoiding toxic or unnecessary therapies
- Reduces risks by protecting against unintentional drug duplication associated with the combined use of prescription and OTC medications
- Enhances the safety of patients being treated by multiple physicians
- Click here to download the PDF
FOR PAYERS
- Supports Drug Utilization Review (DUR)
- Identifies duplications related to ingredients, actions or indications
- Screens for drug duplications with abuse potential
- Improves both clinical and financial outcomes by avoiding toxic or unnecessary therapies
- Reduces risks by protecting against unintentional drug duplication associated with the combined use of prescription and OTC medications
- Enhances the safety of patients being treated by multiple physicians
- Click here to download the PDF
FOR PHARMACISTS
- Supports Drug Utilization Review (DUR)
- Identifies duplications related to ingredients, actions or indications
- Screens for drug duplications with abuse potential
- Improves both clinical and financial outcomes by avoiding toxic or unnecessary therapies
- Reduces risks by protecting against unintentional drug duplication associated with the combined use of prescription and OTC medications
- Enhances the safety of patients being treated by multiple physicians
- Click here to download the PDF